We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Appian
APPN
$1.74B
| $259K | ﹤0.01% |
+4,000
| New | +$216K |
|
1927
Ironwood Pharmaceuticals
IRWD
$611M
| $259K | ﹤0.01% |
28,753
-99,694
| -78% | -$991K |
|
1928
Lindblad Expeditions
LIND
$1.76B
| $259K | ﹤0.01% |
30,399
-29,671
| -49% | -$252K |
|
1929
Organogenesis Holdings
ORGO
$308M
| $259K | ﹤0.01% |
67,502
+46,883
| +227% | +$185K |
|
1930
Clearwater Paper
CLW
$271M
| $258K | ﹤0.01% |
6,800
-1,352
| -17% | -$48.5K |
|
1931
CytomX Therapeutics
CTMX
$705M
| $258K | ﹤0.01% |
38,743
-76,921
| -67% | -$570K |
|
1932
FB Financial Corp
FBK
$2.95B
| $258K | ﹤0.01% |
10,282
-12,118
| -54% | -$313K |
|
1933
Magnachip Semiconductor
MX
$128M
| $258K | ﹤0.01% |
18,823
-32,339
| -63% | -$385K |
|
1934
Loop Industries
LOOP
$38.9M
| $257K | ﹤0.01% |
+18,817
| New | +$203K |
|
1935
CALL
Texas Instruments
TXN
$255B
| $257K | ﹤0.01% |
+1,800
| New | +$245K |
|
|
SLCA
1936
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $257K | ﹤0.01% |
+85,599
| New | +$318K |
|
1937
Anavex Life Sciences
AVXL
$222M
| $256K | ﹤0.01% |
+56,155
| New | +$242K |
|
1938
Transcat
TRNS
$793M
| $256K | ﹤0.01% |
+8,752
| New | +$249K |
|
|
SWI
1939
DELISTED
SolarWinds Corporation Common Stock
SWI
| $256K | ﹤0.01% |
+11,940
| New | +$243K |
|
1940
Sterling Infrastructure
STRL
$20.3B
| $255K | ﹤0.01% |
17,999
-37,831
| -68% | -$475K |
|
|
ATNX
1941
DELISTED
Athenex, Inc. Common Stock
ATNX
| $255K | ﹤0.01% |
+1,053
| New | +$253K |
|
1942
PAR Technology
PAR
$637M
| $254K | ﹤0.01% |
+6,278
| New | +$224K |
|
|
VRAY
1943
DELISTED
ViewRay, Inc.
VRAY
| $254K | ﹤0.01% |
+72,658
| New | +$202K |
|
1944
Heritage Financial
HFWA
$1.24B
| $253K | ﹤0.01% |
13,738
-40
| -0.3% | -$783 |
|
|
SFBS
1945
ServisFirst Bancshares
SFBS
$4.79B
| $253K | ﹤0.01% |
+7,420
| New | +$266K |
|
|
TWCTU
1946
DELISTED
TWC Tech Holdings II Corp. Unit
TWCTU
| $253K | ﹤0.01% |
+25,000
| New | +$253K |
|
1947
Genasys
GNSS
$75.6M
| $252K | ﹤0.01% |
+40,977
| New | +$195K |
|
|
AY
1948
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $252K | ﹤0.01% |
+8,796
| New | +$257K |
|
1949
Scotiabank
BNS
$106B
| $251K | ﹤0.01% |
+6,042
| New | +$254K |
|
1950
Popular Inc
BPOP
$11B
| $251K | ﹤0.01% |
6,918
-79,459
| -92% | -$2.94M |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.